Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population‐Based Study of 1,355 Adults-Reference-Cited by-同舟云学术

Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population‐Based Study of 1,355 Adults

Published:2021-03 Issue:3 Volume:73 Page:968-982
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Alferink Louise J.M.¹^ORCID,Radjabzadeh Djawad²,Erler Nicole S.³^ORCID,Vojinovic Dina⁴,Medina‐Gomez Carolina²,Uitterlinden André G.²⁴,Knegt Robert J.¹^ORCID,Amin Najaf⁴,Ikram M. Arfan⁴,Janssen Harry L.A.⁵,Kiefte‐de Jong Jessica C.⁴⁶,Metselaar Herold J.¹,Duijn Cornelia M.⁴⁷,Kraaij Robert²,Darwish Murad Sarwa¹

Affiliation:

1. Department of Gastroenterology and Hepatology Erasmus Medical Center Rotterdam the Netherlands

2. Department of Internal Medicine Erasmus Medical Center Rotterdam the Netherlands

3. Department of Biostatistics Erasmus Medical Center Rotterdam the Netherlands

4. Department of Epidemiology Erasmus Medical Center Rotterdam the Netherlands

5. Toronto Center of Liver Disease Toronto General HospitalUniversity Health Network Toronto Ontario Canada

6. Department of Public Health and Primary Care/LUMC Campus The Hague Leiden University Medical Center Leiden the Netherlands

7. Nuffield Department of Population Health University of Oxford Oxford United Kingdom

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31417

Reference50 articles.

1. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies;Pimpin L;J Hepatol,2018

2. Protective effect of chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: an experimental approach;Ali N;Chem Biol Interact,2017

3. NAFLD and liver transplantation: current burden and expected challenges;Pais R;J Hepatol,2016

4. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies;Hart CL;BMJ,2010

5. Mechanisms of NAFLD development and therapeutic strategies;Friedman SL;Nat Med,2018

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective;Metabolites;2024-06-07

2. Gut microbiota influence acute pancreatitis through inflammatory proteins: a Mendelian randomization analysis;Frontiers in Cellular and Infection Microbiology;2024-05-31

3. Gut-microbiome composition and function in progression of alcohol-associated liver disease: going beyond western experiences;Hepatology International;2024-05-08

4. Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics;Best Practice & Research Clinical Gastroenterology;2024-05

5. Mendelian randomization reveals association of gut microbiota with Henoch–Schönlein purpura and immune thrombocytopenia;International Journal of Hematology;2024-04-26